The U.S. FDA is recommending a "pause" in using the single-dose Johnson & Johnson C****-** v*****e to investigate reports of potentially dangerous blood clots. The move comes as six Americans have reportedly developed a severe disorder involving blood clots, and one later died, after receiving the shot. The CDC and FDA both said today they are investigating unusual clots that occurred 6 to 13 days after v******tion. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48; there was one death and all remained under investigation.
The reports appear similar to a rare, unusual type of clotting disorder that European authorities say is possibly linked to another C****-** v*****e that has been recalled there, and is not yet cleared in the U.S., from AstraZeneca.
As of yesterday, more than 6.8 million doses of the J&J v*****e have been administered.